Form 4: Organogenesis Director Michele Korfin Receives Stock Grant

Director Michele Ilene Korfin of Organogenesis Holdings Inc. was granted 49,575 restricted stock units (RSUs) on February 19, 2025, vesting fully on February 15, 2026.

Summary

• Michele Ilene Korfin, a director at Organogenesis Holdings Inc., received a grant of 49,575 restricted stock units (RSUs) on February 19, 2025.
• These RSUs, granted under the company's 2018 Equity Incentive Plan, represent the contingent right to receive one share of Organogenesis Class A common stock per unit upon vesting.
• The RSUs will vest in full on February 15, 2026.
• Following the transaction, Ms. Korfin beneficially owns 190,245 shares of Class A Common Stock.

Sentiment

Score: 7

Explanation: The document reflects a routine transaction (stock grant) and doesn't contain any overtly positive or negative information. It's a neutral event from an investment perspective, hence the mid-range score.

Positives

• The grant of RSUs aligns the director's interests with those of the shareholders, incentivizing performance and long-term value creation.
• The vesting schedule encourages continued service and commitment to the company.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

Stock grants to directors are a common practice in publicly traded companies to align their interests with those of shareholders and incentivize long-term value creation. The size and vesting schedule of the grant are typical considerations.

Comparison to Industry Standards

• Director compensation packages, including stock grants, vary significantly across the biotechnology and healthcare industries.
• Companies like Integra LifeSciences and ACell, Inc. also utilize equity-based compensation to incentivize their directors.
• The specific terms of the grant, such as the vesting schedule and the number of shares granted, would need to be compared to peer companies to assess its competitiveness.

Stakeholder Impact

• The stock grant could have a slightly dilutive effect on existing shareholders.
• The grant incentivizes the director to act in the best interests of the company, potentially benefiting all stakeholders.

Key Dates

Keywords

Organogenesis, Director, RSU, Stock Grant, Equity Incentive Plan, Beneficial Ownership, Form 4